This email address is being protected from spambots. You need JavaScript enabled to view it.
Facebook
Twitter
SP_SOCIAL_INSTAGRAM
YouTube
Linkedin
Home
About Us
About Us
Who We Are
Our History
Global Footprint
Careers
Our Partners
Contact Us
Governance
President Emeritus
Board of Directors
Group Executive Management
South Africa Executive Management
Group Technical Leads
What We Do
What We Do
Clinical Research
Implementation Research
Health Programmes
Aurum Global
Global Projects
Aurum Institute Ghana
Fundação Aurum
Expertise
Tuberculosis
HIV
Health Systems
COVID-19
Antimicrobial resistance (AMR)
Accelerate 1
Affiliates
IMPAACT4TB
INNOVA
Youth Health Africa
GHI
Library
Resources
Publications
Annual Reports
Annual Financials
News & Updates
News
Latest News
Press Releases
Aurum in the News
Multimedia
Image Gallery
Multimedia
HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study
Lindquist, L., Kilembe, W., Karita, E., Price, M.A., Kamali, A., Kaleebu, P., Tang, J., Allen, S., Hunter, E., Gilmour, J. and Rowland-Jones, S.L., 2024, April. HLA-A* 23 Is Associated With Lower Odds...
Aurum's Community Engagement Manager joins Global TB Advisory Board
The Aurum Institute is proud to announce that Blossom Makhubalo, our Community Engagement Manager, has been appointed as one of the newest members of the Global Tuberculosis Community Advisory Board (...
Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.
Fwambah, L., Andisi, C., Streatfield, C., Bromell, R., Hare, J., Esbjörnsson, J., Ndung’u, T., Sanders, E.J., Hassan, A.S. and Nduati, E., 2024. Exposure to common infections may shape basal immuni...
Aurum Pharmacy Month Series Part 2: The Power of Collaboration
In celebration of Pharmacy Month, we turn the spotlight on two outstanding pharmacists from our Pretoria site—Liezl Nel and Henriette Bam— whose expertise and dedication is making a significant ...
. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
Moodie, Z., Andersen-Nissen, E., Grunenberg, N., Dintwe, O.B., Omar, F.L., Kee, J.J., Bekker, L.G., Laher, F., Naicker, N., Jani, I. and Mgodi, N.M., 2024. Safety and immunogenicity of a subtype C ALV...
Preventing Stunting in South African Children Under 5: Evaluating the Combined Impacts of Maternal Characteristics and Low Socioeconomic Conditions.
Wand, H., Naidoo, S., Govender, V., Reddy, T. and Moodley, J., 2024. Preventing Stunting in South African Children Under 5: Evaluating the Combined Impacts of Maternal Characteristics and Low Socioeco...
Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective.
Jerome, R.N., Zahn, L.A., Abner, J.J., Joly, M.M., Shirey-Rice, J.K., Wallis, R.S., Bernard, G.R. and Pulley, J.M., 2024. Repurposing N-acetylcysteine for management of non-acetaminophen induced acute...
Prevalence and factors associated with self-reported HIV testing among adolescent girls and young women in Rwanda: evidence from 2019/20 Rwanda Demographic and Health Survey.
Musekiwa, A., Silinda, P., Bamogo, A., Twabi, H.S., Mohammed, M., Batidzirai, J.M., Matsena Zingoni, Z., Singini, G.C., Moyo, M., Mchunu, N.N. and Ekwomadu, T.I., 2022. Prevalence and factors associat...
Facilitators and barriers to uptake of digital adherence technologies in improving TB care in Ethiopia: A qualitative study
Shewamene, Z., Belachew, M., Shiferaw, A., De Groot, L., Sahlie, M., Gadissa, D., Abdurhman, T., Bedru, A., Leta, T., Dube, T. and Deyanova, N., 2024. Facilitators and barriers to uptake of digital ad...
. Impact of coronavirus disease 2019-related clinic closures on HIV incidence in young adult MSM and transgender women in Kenya.
Wahome, E., Otieno, F.O., Kimani, J., Boyd, A., Okall, D., Nzioka, J., Gichuru, E., van der Elst, E., Mehta, S.D., Bailey, R.C. and Graham, S.M., 2022. Impact of COVID-19-related clinic closures on HI...
What is next for BCG revaccination to prevent tuberculosis?
White, R.G., Fiore-Gartland, A.J., Hanekom, W.A., Vekemans, J., Garcia-Basteiro, A.L., Churchyard, G., Rangaka, M.X., Frick, M., Behr, M.A., Hill, P.C. and Mave, V., 2024. What is next for BCG revacci...
Expanding the Evidence on the Safety and Efficiency of 2-Way Text Messaging-Based Telehealth for Voluntary Medical Male Circumcision Follow-up Compared With In-Person Reviews: Randomized Controlled Trial in Rural and Urban South Africa.
Feldacker, C., Pienaar, J., Wasunna, B., Ndebele, F., Khumalo, C., Day, S., Tweya, H., Oni, F., Sardini, M., Adhikary, B. and Waweru, E., 2023. Expanding the Evidence on the Safety and Efficiency of 2...
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis.
Dierig, A., Hoelscher, M., Schultz, S., Hoffmann, L., Jarchow-MacDonald, A., Svensson, E.M., Te Brake, L., Aarnoutse, R., Boeree, M., McHugh, T.D. and Wildner, L.M., 2023. A phase IIb, open-label, ran...
. Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responses.
Krause, R., Warren, C.M., Simmons, J.D., Rebeiro, P.F., Maruri, F., Karim, F., Sterling, T.R., Koethe, J.R., Leslie, A. and Van der Heijden, Y.F., 2023. Failure to decrease HbA1c levels following TB t...
Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.
Pietersen, E., Anderson, K., Cox, H., Dheda, K., Bian, A., Shepherd, B.E., Sterling, T.R., Warren, R.M. and van der Heijden, Y.F., 2023. Variation in missed doses and reasons for discontinuation of an...
Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study.
Naidoo, K., Katz, A.W., Morgan, G., Krishnaveni, R., Lydia, S.T., Sarita, N. and Leila, M.E., 2023. Efficacy and action of the dapivirine vaginal ring as understood by women participating in an open ...
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, p
Borges, Á.H. et al. (2025) ‘Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV‐negative adults successfully treated for dr...
Population-level impact of beliefs and attitudes on vaccine decision-making in South Africa: Results from the COVID-19 vaccine survey (2021/2022).
Wand, H., Vujovich-Dunn, C., Moodley, J., Reddy, T. and Naidoo, S., 2023. Population-level impact of beliefs and attitudes on vaccine decision-making in South Africa: results from the COVID-19 vaccine...
The cascade of care for household contacts of people with drug-resistant TB.
Gomes, I., Garg, T., Churchyard, G., Gupta, A., Hesseling, A.C., Swindells, S., Gurupira, W., Martel, B., Mbata, L., Patil, S. and Riviere, C., 2023. The cascade of care for household contacts of peop...
. Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa.
Mukora, R., Maraba, N., Orrell, C., Jennings, L., Naidoo, P., Mbatha, M.T., Velen, K., Fielding, K., Charalambous, S. and Chetty-Makkan, C.M., 2023. Qualitative study exploring the feasibility of usin...
Enter Part of Title
Display #
5
10
15
20
25
30
50
100
All
Page 11 of 16
Start
6
7
8
9
10
11
12
13
14
15
End
Popular Tags
AurumNews
335
Tuberculosis
175
International
130
Public Health
126
HIV
95
Clinical Research
86
Implementation Research
79
Impaact4tb
63
COVID-19
60
Aurum Ghana
56
Unitaid
43
Aurum Mozambique
29
Most Read
Aurum staff appointed to Vanderbilt University
Aurum delivers life-saving medication to homes
Dablapmeds: A convenient shortcut to medication collection
World Pharmacy Month: Aurum celebrates its pharmacists
Recent Posts
Aurum's OP Team Showcases Best Practices at PHASA 2025
Aurum Showcases Innovation at Global Summit on AI
World TB Day 2025: Mothers and Children at the Heart of TB Prevention
DRTB-HDT Annual Consortium Meeting
Home
About Us
About Us
Who We Are
Our History
Global Footprint
Careers
Our Partners
Contact Us
Governance
President Emeritus
Board of Directors
Group Executive Management
South Africa Executive Management
Group Technical Leads
What We Do
What We Do
Clinical Research
Implementation Research
Health Programmes
Aurum Global
Global Projects
Aurum Institute Ghana
Fundação Aurum
Expertise
Tuberculosis
HIV
Health Systems
COVID-19
Antimicrobial resistance (AMR)
Accelerate 1
Affiliates
IMPAACT4TB
INNOVA
Youth Health Africa
GHI
Library
Resources
Publications
Annual Reports
Annual Financials
News & Updates
News
Latest News
Press Releases
Aurum in the News
Multimedia
Image Gallery
Multimedia